Rocket LabRKLBRevenue: is the business selling more than it used to?
$602M+38% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $602M in 2025, compounding +42% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $769M, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBNet income: how much of that revenue becomes profit?
$-198MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $198M in 2025, more than the $190M it lost the year before. The losses are widening - check the Health chapter for how long the cash lasts.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBHow fast is it growing, year by year?
+38.0%revenue growth, FY 2025
→Revenue grew +38% in 2025 against a five-year average of +90%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBRevenue per share: is your slice growing as fast as the company?
$1.13revenue per share, FY 2025
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Revenue per share reached $1.13 in 2025, compounding +36% a year against +42% for RKLB as a whole. Dilution absorbed about 6.0 points of that growth. Free cash flow per share stands at $-0.61.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBFree cash flow: what is left in real cash after everything?
$-322MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $322M of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBWhere does each dollar of revenue actually go?
→Of $602M in 2025 sales, nothing survives to the bottom line - the journey ends $198M underwater.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBHow much of every sales dollar ends up as free cash?
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBWhat does staying competitive cost, per dollar of sales?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 45% of revenue (capital spending 26%, stock compensation 12%). That share has risen since 2022, so the cost of competing is climbing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBMargins: of every $1 of sales, how much survives each cost layer?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 26 points to -38% since 2022. The bottom line is still negative: costs below the operating line eat what is left.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBWhat does it earn on the money it uses?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of -5% and ROCE of -11% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBWhat has the market paid for RKLB over time?
50.0xP/S today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 50.0x sales, the market is paying +271% more than RKLB's own 5-year median of 13.5x. Expectations are elevated, so more has to go right to justify the price.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBWhat cash return does the business throw off per dollar of market value?
-1.0%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -1.0% of annual free cash flow, less than its 5-year median of -3.9% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBCould it handle its debt if things went wrong?
→The company holds $2.1B in cash against $2M of debt - a net-cash balance sheet, which means a bad year is an inconvenience rather than a threat.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBIs the company's own capital growing?
→The company's own capital grew from $555M in 2023 to $3.5B (+530%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBHow fast is your ownership being diluted - or concentrated?
→The share count grew 7.0% in 2025, averaging 4.4% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBDoes RKLB earn more on its capital than that capital costs?
→RKLB's return on capital is negative at -11.5% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBRKLB has issued or retired shares - did shareholders end up better off?
→RKLB's share count rose +604% from 2020 to 2025 while revenue per share grew +143%. Holders are further ahead than before, though the gain per share is smaller than the growth in the business.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
Rocket LabRKLBAre the people running it buying or selling?
→Insiders sold $396M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 11 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30